Sage Journals: Discover world-class research

Open access

Research article

First published 2023

Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study

Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen [...]

Therapeutic Advances in Drug Safety

Open access

Research article

First published 2025

Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter,observational,real-world study

Die Sang, Yanfang Su, Yurong Zhang [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines

Christine Simmons, Daniel Rayson, Anil Abraham Joy [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Laura Pizzuti, Eriseld Krasniqi, Isabella Sperduti [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Real-World Experience of HER2-Positive Advanced Breast Cancer (ABC) Treatment and Evaluation of Blood Biomarkers in a Public Institution in Latin America (LATAM)

Guillermo Valencia, Patricia Rioja, Olenka Peralta [...]

Breast Cancer: Basic and Clinical Research

Open access

Review article

First published 2026

Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer

Anqi Shang, Yunjing Xiong, Min Li [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2024

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Qingyuan Zhang, Pin Zhang, Min Yan [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2024-8

Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer

Elizabeth Hageman, Mia E. Lussier

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-2

Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

Ibrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı [...]

Tumori Journal

Open access

Research article

First published 2020-8

Eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer patients: safety and efficacy. An Italian experience

Eufemia S. Lutrino, Laura Orlando, Antonio Febbraro [...]

Tumori Journal

Search results